Bruno Gomes

Bruno Gomes is the Head of Early Clinical Development Oncology at Roche. Bruno has 20 years of experience in oncology drug development in the pharma industry, from big pharma, mid-size companies to biotech/startups, with deep expertise in translational medicine and in moving preclinical drugs into the clinic.

He led discovery and translational groups and conducted translational research for small molecules and biologics at Pierre Fabre Pharmaceuticals and iTeos Therapeutics, before heading the Oncology Biomarker activities - including Biomarker, Companion Diagnostics, Pathology and Clinical Imaging - at Roche Pharma Research and Early Development.

Now as the Head of Early Clinical Development Oncology, he oversees and leads the clinical portfolio strategy and execution across several therapeutic modalities and mechanisms of action – e.g. T cell engagers, antibody drug conjugates, targeted immuno-cytokines, small molecules etc. - across solid tumors and heme malignancies from entry into human to entry into pivotal trials.

He is a Doctor in Veterinary Medicine and holds a PhD in Immunology.